Darlene Noci - 15 Jul 2022 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role: Chief Development Officer
Signature: /s/ Deborah A. Miller, attorney-in-fact
Issuer symbol: NUVL
Transactions as of: 15 Jul 2022
Net transactions value: -$67,963
Form type: 4
Filing time: 19 Jul 2022, 17:01:24 UTC
Previous filing: 08 Jul 2022
Next filing: 02 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUVL	Class A Common Stock	Options Exercise	$4,085	+3,782		$1.08^*	3,782	15 Jul 2022	Direct	F1
transaction	NUVL	Class A Common Stock	Sale	$59,925	-3,482	-92%	$17.21	300	15 Jul 2022	Direct	F1, F2
transaction	NUVL	Class A Common Stock	Sale	$5,454	-300	-100%	$18.18	0	15 Jul 2022	Direct	F1, F3
transaction	NUVL	Class A Common Stock	Options Exercise	$108	+100		$1.08^*	100	18 Jul 2022	Direct	F1
transaction	NUVL	Class A Common Stock	Sale	$1,707	-100	-100%	$17.07	0	18 Jul 2022	Direct	F1
transaction	NUVL	Class A Common Stock	Options Exercise	$343	+318		$1.08^*	318	19 Jul 2022	Direct	F1
transaction	NUVL	Class A Common Stock	Sale	$5,412	-318	-100%	$17.02	0	19 Jul 2022	Direct	F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVL	Stock Option (Right to Buy)	Options Exercise	$0	-3,782	-2.5%	$0.000000	145,807	15 Jul 2022	Class A Common Stock	3,782	$1.08	Direct	F1, F5
transaction	NUVL	Stock Option (Right to Buy)	Options Exercise	$0	-100	-0.07%	$0.000000	145,707	18 Jul 2022	Class A Common Stock	100	$1.08	Direct	F1, F5
transaction	NUVL	Stock Option (Right to Buy)	Options Exercise	$0	-318	-0.22%	$0.000000	145,389	19 Jul 2022	Class A Common Stock	318	$1.08	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.99, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) of this Form 4.
F3	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.03 to $18.33, inclusive.
F4	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.04, inclusive.
F5	The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.